147 related articles for article (PubMed ID: 36831182)
1. Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and Prognosis of Breast Cancer.
Miedl H; Oswald D; Haslinger I; Gstoettner M; Wenzl R; Proestling K; Schneeberger C; Yotova I; Schreiber M
Cells; 2023 Feb; 12(4):. PubMed ID: 36831182
[TBL] [Abstract][Full Text] [Related]
2. Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Kawada K; Taira N; Mizoo T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kochi M; Abe Y; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Toyooka S
Breast Cancer; 2021 Mar; 28(2):478-487. PubMed ID: 33185851
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa.
Shahzad S; Khan NU; Sombal W; Shah RU; Khan AU; Iqbal A; Munir I
Mol Biol Rep; 2023 Mar; 50(3):2445-2451. PubMed ID: 36595122
[TBL] [Abstract][Full Text] [Related]
4. Validation of associations between ESR1 variants and breast cancer risk in Chinese cohorts.
Li X; Yao GY; Li FX; Qiu YR; Yang XX
Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525837
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
[TBL] [Abstract][Full Text] [Related]
6. Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women.
Li G; Xiang YB; Courtney R; Cheng JR; Huang B; Long JR; Cai H; Zheng W; Shu XO; Cai Q
Chin J Cancer; 2011 Feb; 30(2):138-43. PubMed ID: 21272446
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population.
Han J; Jiang T; Bai H; Gu H; Dong J; Ma H; Hu Z; Shen H
Breast Cancer Res Treat; 2011 Oct; 129(3):901-7. PubMed ID: 21528353
[TBL] [Abstract][Full Text] [Related]
8. C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Sueta A; Yamamoto S; Hayashi M; Tomiguchi M; Takeshita T; Iwase H
Eur J Hum Genet; 2015 Jul; 23(7):949-56. PubMed ID: 25370037
[TBL] [Abstract][Full Text] [Related]
9. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
[TBL] [Abstract][Full Text] [Related]
10. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
[TBL] [Abstract][Full Text] [Related]
12. Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.
Bailey SD; Desai K; Kron KJ; Mazrooei P; Sinnott-Armstrong NA; Treloar AE; Dowar M; Thu KL; Cescon DW; Silvester J; Yang SY; Wu X; Pezo RC; Haibe-Kains B; Mak TW; Bedard PL; Pugh TJ; Sallari RC; Lupien M
Nat Genet; 2016 Oct; 48(10):1260-6. PubMed ID: 27571262
[TBL] [Abstract][Full Text] [Related]
13. Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk.
Yang Z; Shen J; Cao Z; Wang B
Breast Cancer Res Treat; 2013 May; 139(1):267-75. PubMed ID: 23609471
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
15. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.
Stacey SN; Sulem P; Zanon C; Gudjonsson SA; Thorleifsson G; Helgason A; Jonasdottir A; Besenbacher S; Kostic JP; Fackenthal JD; Huo D; Adebamowo C; Ogundiran T; Olson JE; Fredericksen ZS; Wang X; Look MP; Sieuwerts AM; Martens JW; Pajares I; Garcia-Prats MD; Ramon-Cajal JM; de Juan A; Panadero A; Ortega E; Aben KK; Vermeulen SH; Asadzadeh F; van Engelenburg KC; Margolin S; Shen CY; Wu PE; Försti A; Lenner P; Henriksson R; Johansson R; Enquist K; Hallmans G; Jonsson T; Sigurdsson H; Alexiusdottir K; Gudmundsson J; Sigurdsson A; Frigge ML; Gudmundsson L; Kristjansson K; Halldorsson BV; Styrkarsdottir U; Gulcher JR; Hemminki K; Lindblom A; Kiemeney LA; Mayordomo JI; Foekens JA; Couch FJ; Olopade OI; Gudbjartsson DF; Thorsteinsdottir U; Rafnar T; Johannsson OT; Stefansson K
PLoS Genet; 2010 Jul; 6(7):e1001029. PubMed ID: 20661439
[TBL] [Abstract][Full Text] [Related]
16. Two polymorphisms, rs2046210 and rs3803662, are associated with breast cancer risk in a Vietnamese case-control cohort.
Thanh NTN; Lan NTT; Phat PT; Giang NDT; Hue NT
Genes Genet Syst; 2018 Oct; 93(3):101-109. PubMed ID: 30078824
[TBL] [Abstract][Full Text] [Related]
17. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
[TBL] [Abstract][Full Text] [Related]
18. A common polymorphism near the ESR1 gene is associated with risk of breast cancer: evidence from a case-control study and a meta-analysis.
Guo H; Ming J; Liu C; Li Z; Zhang N; Cheng H; Wang W; Shi W; Shen N; Zhao Q; Li D; Yi P; Wang L; Wang R; Xin Y; Zhao X; Nie X; Huang T
PLoS One; 2012; 7(12):e52445. PubMed ID: 23272245
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.
Pan Z; Fu Z; Song Q; Cao W; Cheng W; Xu X
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323034
[TBL] [Abstract][Full Text] [Related]
20. Non-coding single nucleotide variants affecting estrogen receptor binding and activity.
Bahreini A; Levine K; Santana-Santos L; Benos PV; Wang P; Andersen C; Oesterreich S; Lee AV
Genome Med; 2016 Dec; 8(1):128. PubMed ID: 27964748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
